Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: Pfizer
|
Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: Pfizer
01 June 2012 (68.3 Kb 19 sec) |
This page was last updated: 28 May 2012